Sunday Dec 8
Neuralstem Inc: My Favorite Biotech Going Into 2014
Neuralstem Inc is my favorite biotech going into 2014, and this article will explain why.
Fri Dec 06, 2013
Applied Clinical Trials
ALS Therapy Development Institute and Neurimmune Partner to Advance Treatments for ALS
The research partnership will explore a human monoclonal antibody that targets misfolded superoxide dismutase 1 .
Wed Nov 27, 2013
Cape Cod Times
Sound choice: 'Moya Brennan Irish Christmas' benefit
Celtic singer-songwriter Moya Brennan has traveled around the world and performed in front of millions throughout her 43-year music career.
Contra Costa Times
Piedmont: Group honors ALS patient for outreach, fundraising
Piedmont High School alum Corey Reich was just 21 when he was diagnosed with Amyotrophic Lateral Sclerosis , commonly known as Lou Gehrig's disease.
"Ride for Life" Raises $160,000 for Stony Brook ALS Research and Clinical Care
The Ride for Life Organization, which raises funds and awareness for amyotrophic lateral sclerosis , also known as Lou Gehrig's disease, has just surpassed $160,000 that will be given to Stony Brook University in 2014 to support ALS research and clinical care.
Thu Nov 21, 2013
A Closer Look At Neuralstem's ALS Treatment
Ted Harada, diagnosed with the disease in 2010, has been a walking advertisement for their treatment after two surgeries that he underwent as part of the Phase 1 clinical trials at Emory University.
Tue Nov 19, 2013
Q Therapeutics Receives Orphan Drug Designation From U.S. Food & Drug ...
Granted to drug therapies intended to treat diseases or conditions that affect fewer than 200,000 patients in the United States, Orphan Drug Designation enables companies to benefit from financial incentives from the FDA including seven years of market exclusivity after product marketing clearance, access to federal grant funding opportunities to ... (more)
Wed Nov 13, 2013
An unexpected career, an exceptional life
Michael Gagner of Bakersfield at the 2008 Bakersfield Walk to Defeat ALS, a benefit he helped start in 2004.
Tue Nov 12, 2013
ALS patients with mutations in the SOD1 gene have an unique...
Molecular Genetics and Metabolism , Vol. 105, No. 3. , pp. 472-478, doi:10.1016/j.ymgme.2011.11.201 A specific biochemical marker for early diagnosing and for monitoring disease progression in amyotrophic lateral sclerosis will have important clinical applications.